Characteristics of IPF patients initiating nintedanib, pirfenidone or no antifibrotic treatment in the US

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Ambulatory EMR - OMOP
• Data source(s), other:
  Electronic Medical Records Data (Ambulatory) - US
• Data sources (types):
  Other
• Data sources (types), other:
  IQVIA’s GE Centricity EMR database from October 2013 to April 2018

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.